CD4 and myeloid sarcoma: The increase of the M1 phenotype prior to and during the pathology of MS and the enrichment of the CSF with inflammatory cytokines, such as IL-1β and tumor TNF-α, lead to the rapid activation and proliferation of CD4+ T cells.